KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Change in Acquisitions & Divestments (2023 - 2025)

Biocryst Pharmaceuticals' Change in Acquisitions & Divestments history spans 9 years, with the latest figure at $49.0 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments fell 15.52% year-over-year to $49.0 million; the TTM value through Dec 2025 reached $256.6 million, down 19.92%, while the annual FY2025 figure was $256.6 million, 19.92% down from the prior year.
  • Change in Acquisitions & Divestments reached $49.0 million in Q4 2025 per BCRX's latest filing, down from $73.0 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $148.0 million in Q3 2023 to a low of $35.5 million in Q3 2024.
  • Average Change in Acquisitions & Divestments over 3 years is $80.2 million, with a median of $69.7 million recorded in 2023.
  • The largest YoY upside for Change in Acquisitions & Divestments was 180.66% in 2024 against a maximum downside of 76.03% in 2024.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $129.1 million in 2023, then tumbled by 55.06% to $58.0 million in 2024, then fell by 15.52% to $49.0 million in 2025.
  • Per Business Quant, the three most recent readings for BCRX's Change in Acquisitions & Divestments are $49.0 million (Q4 2025), $73.0 million (Q3 2025), and $58.6 million (Q2 2025).